Accelerating the Development and Validation of New Value-Based Diagnostics by Leveraging Biobanks

导出原文传递

翻译打印收藏纠错

作者： Schneider, Daniel ^[1] ; Riegman, Peter H. J. ^[2] ; Cronin, Maureen ^[3] ; Negrouk, Anastassia ^[4] ; Moch, Holger ^[5] ; Balling, Rudi ^[6] ; Penault-Llorca, Frederiques ^[7] ; Zatloukal, Kurt ^[8] ; Horgan, Denis ^[9]

作者单位： Univ Zurich Hosp, Dept Pathol & Lab Med, Inst Surg Pathol, CH-8091 Zurich, Switzerland ^[1] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg ^[2] Jean Perrin Comprehens Canc Ctr, Dept Pathol, Clermont Ferrand, France ^[3] European Org Res Treatment Canc, Brussels, Belgium ^[4] European Alliance Personalised Med, Brussels, Belgium ^[5] Genom Hlth Int SARL, Quai Seujet 10,3rd Floor, CH-1201 Geneva, Switzerland ^[6] Med Univ Graz, Inst Pathol, Graz, Austria ^[7] Erasmus MC, Dept Pathol, Rotterdam, Netherlands ^[8] Celgene Corp, San Francisco, CA USA ^[9]

关键词 Archived sample Biobanks Biomarkers Biospecimen Informed consent Liquid biopsy Molecular diagnostics Next-generation sequencing Personalized medicine

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交